PSA screening saves lives with early detection of prostate cancer: Study

PSA screening saves lives with early detection of prostate cancer: Study

Prostate-specific antigen (PSA) screening significantly reduces the risk for death from deadly disease of prostate cancer as detection at early stage improves outcomes for patients, a new study claimed.

After disparities in settings and implementation were accounted for, two prostate cancer screening trials provide strong evidence that screening really decreases prostate cancer mortality rates.

The United States Preventive Services Task Force’s current guidelines recommend against PSA screening for detection of prostate cancer as the evidence for the test showed very low odds that it would decrease the risk of dying from the disease.

The new findings suggest that existing guidelines may be revised.

However, questions about how to implement screening to ensure the benefits over the potential harms of over diagnosis and over treatment remains.

The findings of the new study appeared in the most recent edition of the Annals of Internal Medicine.

Category: 
Location: